Rajiv Agarwal

Also affiliated with Indiana University – Purdue University Indianapolis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy”.

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

Clinical Journal of the American Society of Nephrology(2021)10.2215/cjn.15260920

N/A

3.4DataRank · unranked

54 citations

Zien Zhou, Hiddo J.L. Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal +18 more

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension(2022)10.1161/hypertensionaha.122.19744

N/A

2.1DataRank · unranked

98 citations

Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing +8 more

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal(2022)10.1093/ckj/sfac234

N/A

2.0DataRank · unranked

102 citations

Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos +12 more

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab336

N/A

1.7DataRank · unranked

62 citations

Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope +12 more

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

Journal of the American Heart Association(2023)10.1161/jaha.122.028516

N/A

0.459DataRank · unranked

7 citations

Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan +13 more

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf160

N/A

0.253DataRank · unranked

4 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Sung Gyun Kim, Johannes F.E. Mann, Janet B. McGill +10 more

Every obstruction does not need a stent: an important lesson from the ISCHEMIA-CKD trial for kidney-transplant surgeons

Nephrology Dialysis Transplantation(2020)10.1093/ndt/gfaa157

N/A

0DataRank · unranked

2 citations

Rajiv Agarwal, Panagiotis I. Georgianos

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal(2021)10.1093/eurheartj/ehab777

N/A

0DataRank · unranked

1207 citations

Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph +7 more

Can We Study Hypertension in Patients on Dialysis? Yes We Can

American Journal of Kidney Diseases(2020)10.1053/j.ajkd.2020.08.010

N/A

0DataRank · unranked

3 citations

Rajiv Agarwal, Panagiotis I. Georgianos

Ambulatory BP Phenotypes and Their Association with Target Organ Damage and Clinical Outcomes in CKD

Clinical Journal of the American Society of Nephrology(2020)10.2215/cjn.02590220

N/A

0DataRank · unranked

3 citations

Rajiv Agarwal, Panagiotis I. Georgianos

Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials

Nephrology Dialysis Transplantation(2020)10.1093/ndt/gfaa204

N/A

0DataRank · unranked

30 citations

Rajiv Agarwal, Youssef M.K. Farag, Alan G. Jardine, Zeeshan Khawaja, Mark J. Koury +10 more

NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

Journal of General Internal Medicine(2021)10.1007/s11606-021-06659-y

N/A

0DataRank · unranked

19 citations

Wanzhu Tu, Rajiv Agarwal

Hypertension in Chronic Kidney Disease (CKD): Diagnosis, Classification, and Therapeutic Targets

American Journal of Hypertension(2020)10.1093/ajh/hpaa209

N/A

0DataRank · unranked

32 citations

Rajiv Agarwal, Panagiotis I. Georgianos

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

American Heart Journal(2020)10.1016/j.ahj.2020.10.068

N/A

0DataRank · unranked

9 citations

Pablo E. Pérgola, Rajiv Agarwal, Geoffrey A. Block, Youssef M.K. Farag, Alan G. Jardine +16 more

Emerging Role of Clinical Genetics in CKD

Kidney Medicine(2022)10.1016/j.xkme.2022.100435

N/A

0DataRank · unranked

32 citations

Glenn M. Chertow, Katalin Suszták, Adeera Levin, Rajiv Agarwal, Peter Stenvinkel +3 more

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Circulation(2023)10.1161/circulationaha.123.067584

N/A

0DataRank · unranked

312 citations

Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott +11 more

The aftermath of coronavirus disease 2019: devastation or a new dawn for nephrology?

Nephrology Dialysis Transplantation(2020)10.1093/ndt/gfaa094

N/A

0DataRank · unranked

11 citations

Rajiv Agarwal

Blood Pressure Control and the Prevention of Incident CKD: The Disconnect Between Cohort Studies and Randomized Trials

American Journal of Kidney Diseases(2024)10.1053/j.ajkd.2024.07.006

N/A

0DataRank · unranked

0 citations

Rajiv Agarwal

Alport Syndrome Classification and Management

Kidney Medicine(2020)10.1016/j.xkme.2020.05.014

N/A

0DataRank · unranked

98 citations

Rajiv Agarwal, Sripal Bangalore, Arlene B. Chapman, Adeera Levin, Peter Stenvinkel +3 more

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Kidney International(2020)10.1016/j.kint.2020.10.042

N/A

0DataRank · unranked

160 citations

Meg Jardine, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan +15 more